TREM-1 and TREM-2 Expression on CD14⁺ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response

Table 3

Comparison of sarcoidosis and HP subgroups.

	Sarcoidosis: stage I versus stage II	Sarcoidosis: with versus without Lӧfgren syndrome	HP: stage inflammatory versus fibrotic	Sarcoidosis stage I and II versus inflammatory HP
TREM-1%	80.5/18.4/ vs 73.1 /20.2/	79.5/19.2/ vs 76.1/21.9/	37.3/38.8/ vs 30.8/32.3/	76.7/21.2/ vs 26.3/52.8/
Median/IQR/
TREM-1 MFI	44.4/24.5/ vs 39.5/24.3/	39.6/22.0/ vs 40.9/24.3/	26.9/39.1/ vs 24.8/20.7/	40.7/23.3/ vs 25.7/38.8/
Median/IQR/
TREM-2%	37.4/42.1/ vs 26.6/37.7/	34.6/36.5/ vs 35.0/39.9/	40.1/65.2/ vs 45.5/31.4/	34.7/39.0/ vs 34.2/42.7/
Median/IQR/
TREM-2 MFI	8.35/4.0/ vs 7.8/3.4/	4.8/3.1/ vs 5.0/4.2/	7.0/4.8/ vs 7.1/5.3/	5.1/3.9/ vs 6.7/4.6/
Median/IQR/